The global market for Cell-Based Multiplex Assays was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cell-Based Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cell-Based Multiplex Assays include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies, Bio-Techne Corporation, Shimadzu Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Multiplex Assays.

The Cell-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cell-Based Multiplex Assays Market Report

Report Metric	Details
Report Name	Cell-Based Multiplex Assays Market
Segment by Type	Flow Cytometry Fluorescence Detection Multiplex Real-Time PCR Others
Segment by Application	Pharmaceutical & Biotechnology Companies Hospitals & Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies, Bio-Techne Corporation, Shimadzu Biotech, Abcam, Merck, Meso Scale Diagnostics, Promega Corporation, Siemens Healthineers, Boster Biological Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Multiplex Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell-Based Multiplex Assays Market report?

Ans: The main players in the Cell-Based Multiplex Assays Market are Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies, Bio-Techne Corporation, Shimadzu Biotech, Abcam, Merck, Meso Scale Diagnostics, Promega Corporation, Siemens Healthineers, Boster Biological Technology

What are the Application segmentation covered in the Cell-Based Multiplex Assays Market report?

Ans: The Applications covered in the Cell-Based Multiplex Assays Market report are Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Others

What are the Type segmentation covered in the Cell-Based Multiplex Assays Market report?

Ans: The Types covered in the Cell-Based Multiplex Assays Market report are Flow Cytometry, Fluorescence Detection, Multiplex Real-Time PCR, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell-Based Multiplex Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Flow Cytometry

1.2.3 Fluorescence Detection

1.2.4 Multiplex Real-Time PCR

1.2.5 Others

1.3 Market by Application

1.3.1 Global Cell-Based Multiplex Assays Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Hospitals & Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell-Based Multiplex Assays Market Perspective (2020-2031)

2.2 Global Cell-Based Multiplex Assays Growth Trends by Region

2.2.1 Global Cell-Based Multiplex Assays Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cell-Based Multiplex Assays Historic Market Size by Region (2020-2025)

2.2.3 Cell-Based Multiplex Assays Forecasted Market Size by Region (2026-2031)

2.3 Cell-Based Multiplex Assays Market Dynamics

2.3.1 Cell-Based Multiplex Assays Industry Trends

2.3.2 Cell-Based Multiplex Assays Market Drivers

2.3.3 Cell-Based Multiplex Assays Market Challenges

2.3.4 Cell-Based Multiplex Assays Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell-Based Multiplex Assays Players by Revenue

3.1.1 Global Top Cell-Based Multiplex Assays Players by Revenue (2020-2025)

3.1.2 Global Cell-Based Multiplex Assays Revenue Market Share by Players (2020-2025)

3.2 Global Cell-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cell-Based Multiplex Assays Revenue

3.4 Global Cell-Based Multiplex Assays Market Concentration Ratio

3.4.1 Global Cell-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Multiplex Assays Revenue in 2024

3.5 Global Key Players of Cell-Based Multiplex Assays Head office and Area Served

3.6 Global Key Players of Cell-Based Multiplex Assays, Product and Application

3.7 Global Key Players of Cell-Based Multiplex Assays, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell-Based Multiplex Assays Breakdown Data by Type

4.1 Global Cell-Based Multiplex Assays Historic Market Size by Type (2020-2025)

4.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2026-2031)

5 Cell-Based Multiplex Assays Breakdown Data by Application

5.1 Global Cell-Based Multiplex Assays Historic Market Size by Application (2020-2025)

5.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cell-Based Multiplex Assays Market Size (2020-2031)

6.2 North America Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cell-Based Multiplex Assays Market Size by Country (2020-2025)

6.4 North America Cell-Based Multiplex Assays Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell-Based Multiplex Assays Market Size (2020-2031)

7.2 Europe Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cell-Based Multiplex Assays Market Size by Country (2020-2025)

7.4 Europe Cell-Based Multiplex Assays Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell-Based Multiplex Assays Market Size (2020-2031)

8.2 Asia-Pacific Cell-Based Multiplex Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2020-2025)

8.4 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cell-Based Multiplex Assays Market Size (2020-2031)

9.2 Latin America Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cell-Based Multiplex Assays Market Size by Country (2020-2025)

9.4 Latin America Cell-Based Multiplex Assays Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell-Based Multiplex Assays Market Size (2020-2031)

10.2 Middle East & Africa Cell-Based Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2020-2025)

10.4 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Cell-Based Multiplex Assays Introduction

11.1.4 Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 R&D Systems

11.2.1 R&D Systems Company Details

11.2.2 R&D Systems Business Overview

11.2.3 R&D Systems Cell-Based Multiplex Assays Introduction

11.2.4 R&D Systems Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.2.5 R&D Systems Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Cell-Based Multiplex Assays Introduction

11.3.4 Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Protavio

11.4.1 Protavio Company Details

11.4.2 Protavio Business Overview

11.4.3 Protavio Cell-Based Multiplex Assays Introduction

11.4.4 Protavio Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.4.5 Protavio Recent Development

11.5 Illumina

11.5.1 Illumina Company Details

11.5.2 Illumina Business Overview

11.5.3 Illumina Cell-Based Multiplex Assays Introduction

11.5.4 Illumina Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.5.5 Illumina Recent Development

11.6 BD

11.6.1 BD Company Details

11.6.2 BD Business Overview

11.6.3 BD Cell-Based Multiplex Assays Introduction

11.6.4 BD Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.6.5 BD Recent Development

11.7 Luminex Corporation

11.7.1 Luminex Corporation Company Details

11.7.2 Luminex Corporation Business Overview

11.7.3 Luminex Corporation Cell-Based Multiplex Assays Introduction

11.7.4 Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.7.5 Luminex Corporation Recent Development

11.8 Agilent Technologies

11.8.1 Agilent Technologies Company Details

11.8.2 Agilent Technologies Business Overview

11.8.3 Agilent Technologies Cell-Based Multiplex Assays Introduction

11.8.4 Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.8.5 Agilent Technologies Recent Development

11.9 Bio-Techne Corporation

11.9.1 Bio-Techne Corporation Company Details

11.9.2 Bio-Techne Corporation Business Overview

11.9.3 Bio-Techne Corporation Cell-Based Multiplex Assays Introduction

11.9.4 Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.9.5 Bio-Techne Corporation Recent Development

11.10 Shimadzu Biotech

11.10.1 Shimadzu Biotech Company Details

11.10.2 Shimadzu Biotech Business Overview

11.10.3 Shimadzu Biotech Cell-Based Multiplex Assays Introduction

11.10.4 Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.10.5 Shimadzu Biotech Recent Development

11.11 Abcam

11.11.1 Abcam Company Details

11.11.2 Abcam Business Overview

11.11.3 Abcam Cell-Based Multiplex Assays Introduction

11.11.4 Abcam Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.11.5 Abcam Recent Development

11.12 Merck

11.12.1 Merck Company Details

11.12.2 Merck Business Overview

11.12.3 Merck Cell-Based Multiplex Assays Introduction

11.12.4 Merck Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.12.5 Merck Recent Development

11.13 Meso Scale Diagnostics

11.13.1 Meso Scale Diagnostics Company Details

11.13.2 Meso Scale Diagnostics Business Overview

11.13.3 Meso Scale Diagnostics Cell-Based Multiplex Assays Introduction

11.13.4 Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.13.5 Meso Scale Diagnostics Recent Development

11.14 Promega Corporation

11.14.1 Promega Corporation Company Details

11.14.2 Promega Corporation Business Overview

11.14.3 Promega Corporation Cell-Based Multiplex Assays Introduction

11.14.4 Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.14.5 Promega Corporation Recent Development

11.15 Siemens Healthineers

11.15.1 Siemens Healthineers Company Details

11.15.2 Siemens Healthineers Business Overview

11.15.3 Siemens Healthineers Cell-Based Multiplex Assays Introduction

11.15.4 Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.15.5 Siemens Healthineers Recent Development

11.16 Boster Biological Technology

11.16.1 Boster Biological Technology Company Details

11.16.2 Boster Biological Technology Business Overview

11.16.3 Boster Biological Technology Cell-Based Multiplex Assays Introduction

11.16.4 Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2020-2025)

11.16.5 Boster Biological Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Bio Techne Corporation

Shimadzu Biotech

Abcam

Merck

Meso Scale Diagnostics

Promega Corporation

Siemens Healthineers

Boster Biological Technology

List of Tables

Table 1. Global Cell-Based Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Flow Cytometry

Table 3. Key Players of Fluorescence Detection

Table 4. Key Players of Multiplex Real-Time PCR

Table 5. Key Players of Others

Table 6. Global Cell-Based Multiplex Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Cell-Based Multiplex Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cell-Based Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Cell-Based Multiplex Assays Market Share by Region (2020-2025)

Table 10. Global Cell-Based Multiplex Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Cell-Based Multiplex Assays Market Share by Region (2026-2031)

Table 12. Cell-Based Multiplex Assays Market Trends

Table 13. Cell-Based Multiplex Assays Market Drivers

Table 14. Cell-Based Multiplex Assays Market Challenges

Table 15. Cell-Based Multiplex Assays Market Restraints

Table 16. Global Cell-Based Multiplex Assays Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Cell-Based Multiplex Assays Market Share by Players (2020-2025)

Table 18. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2024)

Table 19. Ranking of Global Top Cell-Based Multiplex Assays Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Cell-Based Multiplex Assays Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Cell-Based Multiplex Assays, Headquarters and Area Served

Table 22. Global Key Players of Cell-Based Multiplex Assays, Product and Application

Table 23. Global Key Players of Cell-Based Multiplex Assays, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cell-Based Multiplex Assays Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2020-2025)

Table 27. Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2026-2031)

Table 29. Global Cell-Based Multiplex Assays Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2020-2025)

Table 31. Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2026-2031)

Table 33. North America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Cell-Based Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)

Table 48. Thermo Fisher Scientific Company Details

Table 49. Thermo Fisher Scientific Business Overview

Table 50. Thermo Fisher Scientific Cell-Based Multiplex Assays Product

Table 51. Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 52. Thermo Fisher Scientific Recent Development

Table 53. R&D Systems Company Details

Table 54. R&D Systems Business Overview

Table 55. R&D Systems Cell-Based Multiplex Assays Product

Table 56. R&D Systems Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 57. R&D Systems Recent Development

Table 58. Bio-Rad Laboratories Company Details

Table 59. Bio-Rad Laboratories Business Overview

Table 60. Bio-Rad Laboratories Cell-Based Multiplex Assays Product

Table 61. Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 62. Bio-Rad Laboratories Recent Development

Table 63. Protavio Company Details

Table 64. Protavio Business Overview

Table 65. Protavio Cell-Based Multiplex Assays Product

Table 66. Protavio Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 67. Protavio Recent Development

Table 68. Illumina Company Details

Table 69. Illumina Business Overview

Table 70. Illumina Cell-Based Multiplex Assays Product

Table 71. Illumina Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 72. Illumina Recent Development

Table 73. BD Company Details

Table 74. BD Business Overview

Table 75. BD Cell-Based Multiplex Assays Product

Table 76. BD Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 77. BD Recent Development

Table 78. Luminex Corporation Company Details

Table 79. Luminex Corporation Business Overview

Table 80. Luminex Corporation Cell-Based Multiplex Assays Product

Table 81. Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 82. Luminex Corporation Recent Development

Table 83. Agilent Technologies Company Details

Table 84. Agilent Technologies Business Overview

Table 85. Agilent Technologies Cell-Based Multiplex Assays Product

Table 86. Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 87. Agilent Technologies Recent Development

Table 88. Bio-Techne Corporation Company Details

Table 89. Bio-Techne Corporation Business Overview

Table 90. Bio-Techne Corporation Cell-Based Multiplex Assays Product

Table 91. Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 92. Bio-Techne Corporation Recent Development

Table 93. Shimadzu Biotech Company Details

Table 94. Shimadzu Biotech Business Overview

Table 95. Shimadzu Biotech Cell-Based Multiplex Assays Product

Table 96. Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 97. Shimadzu Biotech Recent Development

Table 98. Abcam Company Details

Table 99. Abcam Business Overview

Table 100. Abcam Cell-Based Multiplex Assays Product

Table 101. Abcam Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 102. Abcam Recent Development

Table 103. Merck Company Details

Table 104. Merck Business Overview

Table 105. Merck Cell-Based Multiplex Assays Product

Table 106. Merck Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 107. Merck Recent Development

Table 108. Meso Scale Diagnostics Company Details

Table 109. Meso Scale Diagnostics Business Overview

Table 110. Meso Scale Diagnostics Cell-Based Multiplex Assays Product

Table 111. Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 112. Meso Scale Diagnostics Recent Development

Table 113. Promega Corporation Company Details

Table 114. Promega Corporation Business Overview

Table 115. Promega Corporation Cell-Based Multiplex Assays Product

Table 116. Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 117. Promega Corporation Recent Development

Table 118. Siemens Healthineers Company Details

Table 119. Siemens Healthineers Business Overview

Table 120. Siemens Healthineers Cell-Based Multiplex Assays Product

Table 121. Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 122. Siemens Healthineers Recent Development

Table 123. Boster Biological Technology Company Details

Table 124. Boster Biological Technology Business Overview

Table 125. Boster Biological Technology Cell-Based Multiplex Assays Product

Table 126. Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2020-2025) & (US$ Million)

Table 127. Boster Biological Technology Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Cell-Based Multiplex Assays Picture

Figure 2. Global Cell-Based Multiplex Assays Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cell-Based Multiplex Assays Market Share by Type: 2024 VS 2031

Figure 4. Flow Cytometry Features

Figure 5. Fluorescence Detection Features

Figure 6. Multiplex Real-Time PCR Features

Figure 7. Others Features

Figure 8. Global Cell-Based Multiplex Assays Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Cell-Based Multiplex Assays Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical & Biotechnology Companies Case Studies

Figure 11. Hospitals & Research Institutes Case Studies

Figure 12. Others Case Studies

Figure 13. Cell-Based Multiplex Assays Report Years Considered

Figure 14. Global Cell-Based Multiplex Assays Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Cell-Based Multiplex Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Cell-Based Multiplex Assays Market Share by Region: 2024 VS 2031

Figure 17. Global Cell-Based Multiplex Assays Market Share by Players in 2024

Figure 18. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Cell-Based Multiplex Assays Revenue in 2024

Figure 20. North America Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Cell-Based Multiplex Assays Market Share by Country (2020-2031)

Figure 22. United States Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Cell-Based Multiplex Assays Market Share by Country (2020-2031)

Figure 26. Germany Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Cell-Based Multiplex Assays Market Share by Region (2020-2031)

Figure 34. China Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Cell-Based Multiplex Assays Market Share by Country (2020-2031)

Figure 42. Mexico Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Cell-Based Multiplex Assays Market Share by Country (2020-2031)

Figure 46. Turkey Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Cell-Based Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 50. R&D Systems Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 52. Protavio Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 53. Illumina Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 54. BD Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 55. Luminex Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 56. Agilent Technologies Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 57. Bio-Techne Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 58. Shimadzu Biotech Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 59. Abcam Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 60. Merck Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 61. Meso Scale Diagnostics Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 62. Promega Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 63. Siemens Healthineers Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 64. Boster Biological Technology Revenue Growth Rate in Cell-Based Multiplex Assays Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions